SINGAPORE (Feb 21): The research houses of CIMB, RHB and DBS are reiterating their divided opinions on Raffles Medical Group after it on Monday reported a 1.3% rise in FY16 earnings  to $70.2 million on higher revenue.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $4.99/month*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply